Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2 JPY
−31.41 M JPY
2.43 B JPY
87.82 M
About REPROCELL INCORPORATED
Sector
Industry
Headquarters
Yokohama
Website
Founded
2003
ISIN
JP3974770004
FIGI
BBG004MBZJZ4
ReproCELL, Inc. engages in stem cell research. It operates through the following segments: Research Support and Medical. The Research Support segment includes reagents and drug discovery support in the Induced Pluripotent Stem (iPS) cell business. The Medical segment deals with regenerative medicine in the iPS cell business and clinical testing services. The company was founded by Norio Nakatsuji and Hiromitsu Nakauchi on February 26, 2003 and is headquartered in Yokohama, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4978 is 100 JPY — it has decreased by −1.96% in the past 24 hours. Watch REPROCELL INCORPORATED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange REPROCELL INCORPORATED stocks are traded under the ticker 4978.
4978 stock has fallen by −8.26% compared to the previous week, the month change is a −9.09% fall, over the last year REPROCELL INCORPORATED has showed a −40.48% decrease.
4978 reached its all-time high on Jul 16, 2013 with the price of 2,802 JPY, and its all-time low was 99 JPY and was reached on Dec 20, 2024. View more price dynamics on 4978 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4978 stock is 5.05% volatile and has beta coefficient of 0.73. Track REPROCELL INCORPORATED stock price on the chart and check out the list of the most volatile stocks — is REPROCELL INCORPORATED there?
Today REPROCELL INCORPORATED has the market capitalization of 9.42 B, it has decreased by −3.70% over the last week.
Yes, you can track REPROCELL INCORPORATED financials in yearly and quarterly reports right on TradingView.
REPROCELL INCORPORATED is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4978 earnings for the last quarter are −0.30 JPY per share, whereas the estimation was −1.24 JPY resulting in a 75.81% surprise. The estimated earnings for the next quarter are −0.34 JPY per share. See more details about REPROCELL INCORPORATED earnings.
REPROCELL INCORPORATED revenue for the last quarter amounts to 701.00 M JPY, despite the estimated figure of 560.00 M JPY. In the next quarter, revenue is expected to reach 720.00 M JPY.
4978 net income for the last quarter is −28.96 M JPY, while the quarter before that showed −75.26 M JPY of net income which accounts for 61.52% change. Track more REPROCELL INCORPORATED financial stats to get the full picture.
No, 4978 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 96.00 employees. See our rating of the largest employees — is REPROCELL INCORPORATED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REPROCELL INCORPORATED EBITDA is −275.65 M JPY, and current EBITDA margin is −15.34%. See more stats in REPROCELL INCORPORATED financial statements.
Like other stocks, 4978 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REPROCELL INCORPORATED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REPROCELL INCORPORATED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REPROCELL INCORPORATED stock shows the strong sell signal. See more of REPROCELL INCORPORATED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.